Business Context and Reporting Period
Company: Espey Mfg. & Electronics Corp.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2002
Business Overview: The company engages in development and production contracts, primarily accounted for under the percentage of completion method. The business relies on long-term fixed-price contracts where revenue recognition depends on units of delivery and cost estimation judgments.
Key Financial Metrics
| Metric | Q1 2003 (Sep 30, 2002) | Q1 2002 (Sep 30, 2001) |
|---|---|---|
| Net Sales | $4,491,359 | $4,585,515 |
| Gross Profit | $789,221 | $607,585 |
| Gross Margin | 17.6% | 13.3% |
| Operating Income | $359,914 | $213,553 |
| Net Income | $306,545 | $203,691 |
| Diluted EPS | $0.30 | $0.20 |
| Cash from Operations | $84,404 | $1,340,440 |
| Cash & Equivalents (End) | $8,991,556 | $6,299,899 |
| Working Capital | $23,871,594 | N/A |
| Backlog | $26,239,000 | $24,767,000 |
Liquidity & Debt: The company reported no long-term debt in the balance sheet liabilities section. It maintains an uncommitted $3,000,000 line of credit. Working capital increased to approximately $23.9 million from $23.7 million in the prior quarter.
Material Changes vs. Prior Period
- Revenue: Net sales decreased by $94,156 (2.1%) compared to the prior year quarter. Management attributes this to the timing of shipments on long-term contracts, with deliveries expected in subsequent quarters.
- Profitability: Despite lower sales, Net Income increased by $102,854 (50.5%). Gross profit margin expanded by approximately 4.3% due to lower production costs (reduced labor hours), a favorable product mix, and the implementation of Lean Manufacturing principles.
- Expenses: Selling, general, and administrative (SG&A) expenses increased by $35,275 (8.9%), primarily driven by higher health insurance costs.
- Other Income: Total other income decreased by $28,621 (37%) due to lower interest rates on money market accounts.
- Cash Flow: Net cash provided by operating activities dropped significantly to $84,404 from $1,340,440 in the prior year. This was largely due to a $1.27 million increase in receivables, offset partially by a $272,749 decrease in inventories.
Guidance, Outlook, and Risks
Outlook: Management anticipates an overall increase in net sales for the fiscal year ending June 30, 2003. The company believes current cash balances and operating cash flow will be sufficient to meet funding requirements for the next twelve months.
Management Commentary: The company continues to evaluate its workforce (currently 194 employees) to ensure successful execution of backlog orders. Capital expenditures for the quarter were approximately $208,000.
Risks and Contingencies:
- Contract Estimation: Revenue recognition relies on estimates of costs and completion percentages. Materially different amounts could be recorded if assumptions regarding technical issues or delivery schedules change.
- Forward-Looking Risks: Risks include dependence on timely development and customer acceptance of new products, competition, price erosion, and supply/manufacturing constraints.
- Investment Policy: The company holds preferred equity securities and money market accounts, stating no significant risk associated with this policy.
Investor Verification Checklist
- Backlog Conversion: Verify if the $26.2 million backlog converts to revenue in upcoming quarters as anticipated to offset the current sales timing delay.
- Receivables Collection: Monitor the $3.69 million in trade receivables, which increased significantly ($1.27 million) during the quarter, impacting operating cash flow.
- Cost Estimates: Review future quarters for potential adjustments to contract cost estimates, which could materially impact earnings given the percentage-of-completion accounting method.
- SG&A Trends: Track health insurance costs to determine if the 8.9% increase in SG&A is a one-time anomaly or a recurring trend affecting margins.
- Capital Expenditures: Confirm if the $208,000 in capital expenditures aligns with the company's stated growth strategy and Lean Manufacturing initiatives.